Progress of manlnutrion treatment for dialysis patients
LIU Yangyan1 XIONG Mingxia2 YANG Junwei1，2
1.The Second Clinical Medical College, Nanjing Medical University, Jiangsu Province, Nanjing 210000, China;
2.Department of Nephrology, the Second Affiliated Hospital of Nanjing Medical University, Jiangsu Province, Nanjing 210000, China
Abstract：Malnutrition of dialysis patients, also known as protein-energy wasting malnutrition, is one of the common complications of patients with maintenance hemodialysis, and is associated with high hospitalization rates, mortality/morbidity and adverse clinical outcomes. The pathogenesis of malnutrition of dialysis patients in order to get the full research, inclouding inadequate nutrient intake, metabolic and hormonal disorders and inadequate dialysis and so on. But at the moment, treatment strategy of malnutrition is still lack of attention and not reached a consensus. This article aimes at summarizing the progress of the evaluation and treatment of malnutrition in the dialysis patients.
[1] Kovesdy CP，Kalantar-Zadeh K. Why is protein-energy wasting associated with mortality in chronic kidney disease? [J]. Semin Nephrol，2009，29（1）：3-14.
[2] Sabatino A，Regolisti G，Karupaiah T，et al. Protein-energy wasting and nutritional supplementation in patients with end-stage renal disease on hemodialysis [J]. Clin Nutr，2016：1-9.
[3] Fouque D，Kalantar-Zadeh K，Kopple J，et al. A proposed nomenclature and diagnostic criteria for protein energy wasting in acute and chronic kidney disease [J]. Kidney Int，2008，73（4）：391-398.
[4] Kovesdy CP，Kalantar-Zadeh K. Accuracy and limitations of the diagnosis of malnutrition in dialysis patients [J]. Semin Dial，2012，25（4）：423-427.
[5] Kalantar-Zadeh K，Kopple JD，Block G，et al. A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients [J]. Am J Kidney Dis，2001，38（6）：1251-1263.
[6] Kopple JD. National kidney foundation K/DOQI clinical practice guidelines for nutrition in chronic renal failure [J]. Am J Kidney Dis，2001，37（1 Suppl 2）：S66-S70.
[7] Stratton RJ，Bircher G，Fouque D，et al. Multinutrient oral supplements and tube feeding in maintenance dialysis：a systematic review and meta-analysis [J]. Am J Kidney Dis，2005，46（3）：387-405.
[8] 付艳娜，广翠兰，宋艳红，等.肾病型肠内营养制剂在在维持性透析并发营养不良的病人中的疗效分析[J].肠外与肠内营养，2016，23（5）：283-289.
[9] Pupim LB，Flakoll PJ，Brouillette JR，et al. Intradialytic parenteral nutrition improves protein and energy homeostasis in chronic hemodialysis patients [J]. J Clin Invest，2002，110（4）：483-492.
[10] Marsen TA，Beer J，Mann H，et al. Intradialytic parenteral nutrition in maintenance hemodialysis patients suffering from protein-energy wasting. Results of a multicenter, open, prospective, randomized trial [J]. Clin Nutr，2017， 36（1）：107-117.
[11] Pedrini LA，De C，Comelli M，et al. Long-term effects of high-efficiency online haemodiafiltration on uraemic toxicity. A multicentre prospective randomized study [J]. Nephrol Dial Transplant，2011，26（8）：2617-2624.
[12] Carrero JJ. Identification of patients with eating disorders：clinical and biochemical signs of appetite loss in dialysis patients [J]. J Ren Nutr，2009，19（1）：10-15.
[13] Yeh S，Wu SY，Levine DM，et al. Quality of life and stimulation of weight gain after treatment with megestrol acetate：correlation between cytokine levels and nutritional status，appetite in geriatric patients with wasting syndrome [J]. J Nutr Health Aging，2000，4（4）：246-251.
[14] Tonshoff B，Schaefer F，Mehls O. Disturbance of growth hormone-insulin-like growth factor axis in uraemia. Implications for recombinant human growth hormone treatment [J]. Pediatr Nephrol，1990，4（6）：654-662.
[15] Ericsson F，Filho JC，Lindgren BF. Growth hormone treatment in hemodialysis patients—a randomized，double-blind，placebo-controlled study [J]. Scand J Urol Nephrol，2004，38（4）：340-347.
[16] Feldt-Rasmussen B，Lange M，Sulowicz W，et al. Growth hormone treatment during hemodialysis in a randomized trial improves nutrition，quality of life，and cardiovascular risk [J]. J Am Soc Nephrol，2007，18（7）：2161-2171.
[17] Graham KA，Reaich D，Channon SM，et al. Correction of acidosis in hemodialysis decreases whole body protein degradation [J]. J Am Soc Nephrol，1997，8（4）：632-637.
[18] Ikizler TA，Cano NJ，Franch H，et al. Prevention and treatment of protein energy wasting in chronic kidney disease patients：a consensus statement by the international society of renal nutrition and metabolism [J]. Kidney Int，2013，84（6）：1096-1107.
[19] Tentori F，Karaboyas A，Robinson BM，et al. Association of dialysate bicarbonate concentration with mortality in the dialysis outcomes and practice patterns study（DOPPS） [J]. Am J Kidney Dis，2013，62（4）：738-746.
[20] Kim JC，Shapiro BB，Zhang M，et al. Daily physical activity and physical function in adult maintenance hemodialysis patients [J]. J Cachexia Sarcopenia Muscle，2014，5（3）：209-220.
[21] Cheema BS，Chan D，Fahey P，et al. Effect of progressive resistance training on measures of skeletal muscle hypertrophy，muscular strength and health-related quality of life in patients with chronic kidney disease：a systematic review and meta-analysis [J]. Sports Med，2014，44（8）：1125-1138.
[22] Sehomig M，Eisenhandt A，Ritz E. The microinflammatory state of uremia [J]. Blood Purif，2000，18（4）：327-332.
[23] Ikizler TA. Nutrition，inflammation and chronic kidney disease [J]. Curr Opin Nephrol Hypertens，2008，17（2）：162-167.
[24] Biolo G，Ciocchi B，Bosutti A，et al. Pentoxifylline acutely reduces protein catabolism in chronically uremic patients [J]. Am J Kidney Dis，2002，40（6）：1162-1172.
[25] Hung AM，Ellis CD，Shintani A，et al. IL-1 beta receptor antagonist reduces inflammation in hemodialysis patients [J]. J Am Soc Nephrol，2011，22（3）：437-442.
[26] Palmer SC，Hayen A，Macaskill P，et al. Serum levels of phosphorus，parathyroid hormone，and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease：a systematic review and meta-analysis [J]. JAMA，2011，305（11）：1119-1127.
[27] Lertdumrongluk P，Rhee CM，Park J，et al. Association of serum phosphorus concentration with mortality in elderly and nonelderly hemodialysis patients [J]. J Ren Nutr，2013， 23（6）：411-421.
[28] Streja E，Lau WL，Goldstein L，et al. Hyperphosphatemia is a combined function of high serum PTH and high dietary protein intake in dialysis patients [J]. Kidney Int Suppl，2013，3（5）：462-468.
[29] Yamada S，Tokumoto M，Tatsumoto N，et al. Phosphate overload directly induces systemic inflammation and malnutrition as well as vascular calcification in uremia [J]. Am J Physiol Renal Physiol，2014，306（12）：1418-1428.
2017, Vol. 14 
京公网安备 11010502046598号